Align Technology | 11,120.00 / +4.32% |
Date/Time | 01/12 / 00:00 |
Chg. / Chg.(%) | 460.00 / +4.32% |
Bid | - |
Ask | - |
Open | 11,120.00 |
Previous Close | 10,660.00 |
High | 11,120.00 |
Low | 11,120.00 |
Volume [MXN] | - |
Volume [Units] | 8 |
Price fixings | |
ISIN | US0162551016 |
Security | ALGN |
Exchange | Mexico |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 473.05 | ![]() |
|
NASDAQ | 567.2300 | ![]() |
551,686 |
IEX | 567.37 | ![]() |
35,753 |
Cboe US | 567.33 | ![]() |
33,760 |
TradeGate | 470.00 | ![]() |
160 |
Xetra | 459.45 | ![]() |
104 |
London Inter.. | 551.25 | ![]() |
31 |
Stuttgart | 468.500 | ![]() |
26 |
gettex | 467.700 | ![]() |
7 |
Frankfurt | 458.8500 | ![]() |
5 |
München | 454.25 | ![]() |
0 |
Düsseldorf | 453.95 | ![]() |
0 |
Berlin | 453.70 | ![]() |
0 |
Vienna Globa.. | 460.65 | ![]() |
0 |
Mexico | 11,120.00 | ![]() |
8 |
News
- The new name and governance of Stellantis take effect
20:25 - GlobeNewswire - ROSEN, A LEADING LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GDRX
16:00 - GlobeNewswire - Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
16:00 - GlobeNewswire - ROSEN, A TRUSTED LAW FIRM, Reminds Covia Holdings Corporation f/k/a Fairmount Santrol Holdings Inc. Investors of Important February 8 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CVIAQ, CVIA, FMSA
15:00 - GlobeNewswire - Align Technology to Announce Fourth Quarter and 2020 Results on February 3, 2021
01/04/2021 / 14:30 - GlobeNewswire